Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Leases (2016 - 2026)

Champions Oncology has reported Leases over the past 15 years, most recently at $4.0 million for Q1 2026.

  • For Q1 2026, Leases fell 25.03% year-over-year to $4.0 million; the TTM value through Jan 2026 reached $4.0 million, down 25.03%, while the annual FY2025 figure was $5.1 million, 18.75% down from the prior year.
  • Leases for Q1 2026 was $4.0 million at Champions Oncology, down from $4.3 million in the prior quarter.
  • Over five years, Leases peaked at $8.4 million in Q1 2022 and troughed at $4.0 million in Q1 2026.
  • A 5-year average of $6.4 million and a median of $6.5 million in 2024 define the central range for Leases.
  • Biggest five-year swings in Leases: skyrocketed 56.47% in 2022 and later dropped 25.03% in 2026.
  • Year by year, Leases stood at $7.7 million in 2022, then fell by 11.46% to $6.8 million in 2023, then decreased by 16.83% to $5.7 million in 2024, then dropped by 23.3% to $4.3 million in 2025, then decreased by 7.41% to $4.0 million in 2026.
  • Business Quant data shows Leases for CSBR at $4.0 million in Q1 2026, $4.3 million in Q4 2025, and $4.8 million in Q3 2025.